Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver, often arising in the context of chronic liver disease and cirrhosis.

Definition

Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver, often arising in the context of chronic liver disease and cirrhosis.

Epidemiology

  • Sixth most common cancer worldwide and third leading cause of cancer-related death
  • Higher prevalence in East Asia, sub-Saharan Africa, and regions with high hepatitis B and C prevalence
  • Peak incidence: 50–70 years
  • Male predominance (2–4:1 ratio)
  • Majority of cases occur in patients with underlying chronic liver disease

Etiology

  • Chronic hepatitis B virus (HBV) infection (major risk factor globally)
  • Chronic hepatitis C virus (HCV) infection
  • Alcohol-related liver disease and cirrhosis
  • Nonalcoholic fatty liver disease (NAFLD/NASH)
  • Aflatoxin exposure, hemochromatosis, primary biliary cholangitis
  • Genetic syndromes and metabolic disorders (e.g., Wilson disease)

Pathophysiology

  • Chronic liver injury and inflammation lead to fibrosis and cirrhosis
  • Hepatocyte regeneration under oxidative stress predisposes to genetic mutations
  • Activation of oncogenes (e.g., TERT, CTNNB1) and inactivation of tumor suppressor genes (TP53, AXIN1)
  • Angiogenesis and vascular invasion promote tumor growth and metastasis
  • Progression can be nodular, massive, or infiltrative
Messenger Icon